Medically integrated dispensing improves affordability, adherence, and toxicity management via embedded pharmacy teams, ...

Reflex molecular testing and nurse navigation cut delays in lung cancer care, helping more patients get targeted results ...

Accurate detection of PIK3CA mutations is essential for personalizing breast cancer treatment, particularly with ...

New NCCN guidelines highlight how structured exercise and molecular profiling significantly reduce recurrence rates. Regular exercise is no longer just a recommendation for general health; it is now a ...

The free lodging, meals, and support Duane received as a guest at Hope Lodge Baltimore made it possible for him to take part ...

An experimental drug targeting triple-negative breast cancer overwhelms cancer cells with toxic fats, according to new tests ...

A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...

Scientists at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine developed BiliSeq, a molecular test that detected bile duct cancer with twice the sensitivity of the ...

Qlucore, listed on Nasdaq First North, is launching a new Qlucore Insights test (Research Use Only) specifically developed for bladder cancer samples. The software-based test delivers multiple ...

Cancer treatment is undergoing a quiet revolution. Increasingly, what matters most is not where a tumour begins, but what is ...

New research provides compelling evidence that Barrett’s esophagus underlies all cases of esophageal adenocarcinoma, even ...

At SGO 2026, Alison Schram, MD, highlighted first-in-class tumor suppressor reactivation and emphasized early NGS testing in ...